Invitae Corporation (NVTA) financial statements (2021 and earlier)

Company profile

Business Address 1400 16TH STREET
SAN FRANCISCO, CA 94103
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3921266593127
Cash and cash equivalents151112126773
Short-term investments24014532654
Other undisclosed cash, cash equivalents, and short-term investments   (0) 
Receivables332610  
Inventory, net of allowances, customer advances and progress billings78   
Inventory78   
Other undisclosed current assets1151294
Total current assets:44216587102131
Noncurrent Assets
Finance lease, right-of-use asset6
Operating lease, right-of-use asset37
Property, plant and equipment3828302419
Long-term investments and receivables  6  
Long-term investments  6  
Intangible assets, net (including goodwill)2528182  
Goodwill1275047  
Intangible assets, net (excluding goodwill)1253036  
Other noncurrent assets73102
Other undisclosed noncurrent assets16555
Total noncurrent assets:3391181242925
TOTAL ASSETS:782283211131157
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities753431108
Accounts payable108934
Accrued liabilities65272374
Debt72232
Other undisclosed current liabilities   12
Total current liabilities:8236331511
Noncurrent Liabilities
Long-term debt and lease obligation312764297
Long-term debt, excluding current maturities269743996
Finance lease, liability1
Capital lease obligations1302
Operating lease, liability42
Liabilities, other than long-term debt891380
Other liabilities891380
Total noncurrent liabilities:3208556177
Total liabilities:402121893218
Stockholders' equity
Stockholders' equity attributable to parent38016212299138
Common stock00000
Additional paid in capital1,138679521374313
Accumulated other comprehensive loss(0)(0)(0) (0)
Accumulated deficit(759)(517)(399)(275)(175)
Total stockholders' equity:38016212299138
TOTAL LIABILITIES AND EQUITY:782283211131157

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues21714868258
Cost of revenue(118)(80)(48)(28)(17)
Gross profit:996820(3)(8)
Operating expenses(343)(190)(141)(97)(81)
Operating loss:(244)(123)(121)(100)(89)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(4)(3)(0)0(0)
Interest and debt expense(12)(7)(4)(0)(0)
Loss from continuing operations before income taxes:(260)(132)(125)(100)(90)
Income tax benefit1832  
Net loss available to common stockholders, diluted:(242)(129)(123)(100)(90)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(242)(129)(123)(100)(90)
Other comprehensive income 0   
Comprehensive loss:(242)(129)(123)(100)(90)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0) (0)0(0)
Comprehensive loss, net of tax, attributable to parent:(242)(129)(124)(100)(90)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: